K&L Gates competitors

Joe Conroy is the chief executive officer of Cooley and leads its management committee. As partner and CEO - a role he has held since 2008 - he sets and executes the firm’s strategy.

Brian L. Duffy assumed the role of Chief Executive Officer at Greenberg Traurig, LLP in January 2016. Previously Brian served as a firm President as well as chair of the firm’s 600-member Global Litigation Department from 2009 to 2013. A true “working CEO,” Brian focuses his practice on trial and appellate work in the class action, employment, energy, commercial contract, and product liability areas, serving as national, regional, and local counsel in high-profile cases throughout the US. Under Brian’s leadership, Greenberg Traurig received important rankings reflective of his and the firm’s commitment to a diverse and quality workplace. Brian is involved with the leadership and direction of the firm’s diversity efforts, including the independently recognized Greenberg Traurig Women’s Initiative and its Affinity Groups, addressing the needs of minority and diverse attorneys throughout the firm. The firm’s work includes forging important relationships with key organizations. As one example of many, Brian serves on the Out Leadership Global Advisory Board. Since Brian began his tenure as CEO, Greenberg Traurig has received a distinguished set of awards and accolades in the pro bono arena, one of his key areas of focus including the Distinguished Service to the Arts Award from Lawyers for the Creative Arts; the Common Good (Pro Bono) Award from Big Brothers Big Sisters of America; the Hope Award from The Center of Hope (Haiti); the Champion of Justice Award from the Domestic Violence Legal Clinic; and was honored at the Equal Justice Works 30th Anniversary. During Brian’s time at Greenberg Traurig, the firm has assisted hundreds of charitable organizations through its Philanthropic Foundation, resulting in real-life positive impact on communities throughout the United States where the firm has offices and clients. Additionally, the Greenberg Traurig Fellowship Foundation continues to provide funding for lawyers and law students to work with public interest groups. The Foundation became the largest sponsor of Equal Justice Works Fellowships in the United States. Brian holds a J.D. from the University of Colorado Law School, where he was honored as Outstanding Alumni in private practice. He received a B.S., summa cum laude, from the University of South Dakota.

PROFESSIONAL PROFILE: LEADERSHIP AND EXPERIENCEI have substantial experience in the HE sector at the highest levels of senior management both through my present appointment as Senior Vice-President (Global) and in my previous roles of Acting Deputy Vice-Chancellor (Research and Innovation) and Pro Vice-Chancellor (International relations) at the University of Surrey. Prior to joining Surrey in September 2012, during my tenure at UCL I was a significant contributor to the senior management team of the School of Life and Medical Sciences and Faculty of Biomedical Sciences and a major lead on quality assurance (in both teaching and learning and research) for the University. I also spearheaded our regional engagement programme through my role as a Pro-Provost. Most of my roles require, or have required, significant diplomatic skills and an ability to lead multidisciplinary complex teams in order to deliver the desired outcomes without the individuals necessarily being under my direct line management. Effective communication and ability to articulate a vision has been instrumental in achieving success together with effective use of networks of key individuals to deliver strategies . I am well versed in leading significant organisational change through engagement and persuasion. I regularly speak at Higher Education, research and International Summits in the UK and globally relating to research led teaching, building academic links with Asia, opportunities for educational development between the UK and other countries and university governance and management of strategic international developments. I sit or have sat on advisory boards for a range of Biotech and large Pharma companies including Roche, Novartis, MSD, Janssen, Johnsons and Johnson and also SMEs in the biotech sector. I have also undertaken medico-legal work as an advisor/witness for both defence and prosecution cases relating to organ transplantation and infectious diseases.

Mark Ruehlmann is a Chairman/CEO:Global at Squire Patton Boggs. He has worked as Partner at Squire Patton Boggs. Mark studied at Gamma Beta Phi Society, University Of Notre - Dam Do Lek, and University of Notre Dame.